An article in the Sunshine Coast Daily, Australia, describes why a Pompe sufferer goes to the U.S. to...

Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for...

Access to Therapy in Australia {youtube}Lmn5nknO9JM{/youtube}

After Sanofi’s acquisition of Genzyme patients hope that they will “remain at the heart of Genzyme’s work”, as...

“Paris, France and Cambridge, Massachusetts – February 16, 2011 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Genzyme...

After months of rumours and negotiations, the buy-out of Genzyme by pharma giant Sanofi-Aventis (SA) looks soon to...

February 3, 2011 | 8pm (ET) – 7pm (CT) – 6pm (MT) – 5pm (PT) Genzyme’s Next Generation...

January 2x, 2011 Telephone Conference of the IPA Board Please contact the IPA if you have items that...

Genzyme today announced that it will build an additional manufacturing plant in Geel, Belgium, to support the long-term...

BioMarin Pharmaceutical Inc. announced today that it has initiated a Phase 1/2 trial for BMN 701, a novel...